封面
市場調查報告書
商品編碼
1946978

2026年全球即時檢測HbA1c市場報告

Poc Hba1C Testing Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,即時檢測糖化血紅素(HbA1c)市場發展迅速,預計2025年至2026年間,該市場將以11.9%的複合年成長率從10.2億美元成長至11.4億美元。過去幾年的成長歸因於全球糖尿病患者數量的增加、臨床對長期血糖監測的依賴性增強、門診診斷服務的擴展、人們對早期糖尿病診斷意識提升以及小型診斷設備的普及等因素。

預計未來幾年,即時檢測糖化血紅蛋白 (HbA1c) 市場將快速成長,到 2030 年市場規模將達到 17.6 億美元,複合年成長率 (CAGR) 為 11.4%。預測期內的成長要素包括:分散式診斷的日益普及、對居家照護檢測解決方案需求的成長、數位化糖尿病管理項目的擴展、對預防性護理的日益重視以及對快速診斷技術投資的增加。預測期內的主要趨勢包括:快速照護現場(POC) HbA1c 監測設備的日益普及、攜帶式和手持式檢測系統的使用日益增多、對居家糖尿病監測的需求不斷成長、整合式 POC 診斷平台的擴展以及對檢測準確性和標準化的日益重視。

全球糖尿病負擔日益加重,推動了照護現場檢測(POC​​)糖化血紅蛋白(HbA1c)的需求成長。糖尿病是一種慢性代謝性疾病,其特徵是血糖值持續升高,需要定期監測以降低併發症風險,例如神經病變、心血管疾病和腎臟損傷。糖尿病發生率上升的主要原因是久坐的生活方式、不良的飲食習慣、肥胖率上升以及全球人口老化。因此,診所、藥房和居家照護機構對快速、便利、可靠的血糖值檢測的需求日益成長,而即時檢測HbA1c有助於及時做出臨床決策。例如,根據國際糖尿病聯盟(IDF)的數據,到2024年,20至79歲糖尿病患者人數將達到約5.89億,預計2050年將增加至8.53億。此外,超過80%的糖尿病患者居住在中低收入國家。不斷擴大的患者群體為即時檢測HbA1c的持續成長提供了支持。

在即時檢測 (POC) HbA1c 領域營運的公司正在加速採用內建的內部檢驗系統,以提高準確性、最大限度地減少誤差並增強對床邊診斷的信心。這些自動化自我檢測功能持續評估每次檢測的環境條件、檢體品質和檢測性能,有助於防止不準確的結果。例如,西門子醫療於 2024 年 7 月推出了用於即時檢測的下一代 Atelica DCA 分析儀。該系統整合了專有的 AutoCheck 技術,可在整個檢測過程中進行持續的內部校準,包括檢查環境穩定性、氣流和溫度控制、檢體量和完整性、光學清晰度和分析準確性。這種自動化監控功能減少了對操作人員的監督需求,並可在四到五分鐘內提供檢查室品質的 HbA1c 結果。這些功能有助於降低分析前誤差率,提高結果可靠性,並促進在資源匱乏地區廣泛採用就地檢驗。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球即時檢測糖化血紅素(HbA1c)市場:吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧(AI)和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 快速照護現場(HbA1c) 設備的應用日益普及
    • 攜帶式和手持式測試系統的日益普及
    • 對家用糖尿病監測的需求日益成長
    • 擴展整合式即時診斷平台
    • 越來越重視測試的準確性和標準化

第5章 終端用戶產業市場分析

  • 醫院
  • 診所和門診中心
  • 診斷檢查室
  • 居家照護提供者
  • 糖尿病護理診所

第6章 市場:宏觀經濟情景,包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響,以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球即時檢測HbA1c市場:PESTEL分析(政治、社會、技術、環境、法律因素、促進因素與限制因素)
  • 全球即時檢測HbA1c市場規模、對比及成長率分析
  • 全球即時檢測糖化血紅素(HbA1c)市場表現:規模與成長,2020-2025年
  • 全球即時檢測糖化血紅素(HbA1c)市場預測:規模與成長,2025-2030年,2035年預測

第8章 全球潛在市場規模(TAM)

第9章 市場細分

  • 依產品類型
  • 設備、耗材
  • 透過技術
  • 離子交換親和性層析法、酵素法、親和層析法、免疫檢測及其他技術
  • 最終用戶
  • 醫院、診所或門診中心、居家醫療和其他最終用戶
  • 按類型細分:設備
  • 攜帶式糖化血紅素(HbA1c)測量儀、可攜式糖化血紅素分析儀、桌上型糖化血紅素測量系統、整合式就地檢驗系統
  • 按類型細分:消耗品
  • 試紙、質控液、試劑、校正液、檢體採集裝置

第10章 區域與國家分析

  • 全球即時檢測糖化血紅素 (HbA1c) 市場:按地區、績效和預測分類,2020-2025 年、2025-2030 年預測、2035 年預測
  • 全球即時檢測糖化血紅素 (HbA1c) 市場:國家、市場表現及預測,2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章:中國市場

第13章 印度市場

第14章 日本市場

第15章:澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章:西歐市場

第21章英國市場

第22章 德國市場

第23章:法國市場

第24章:義大利市場

第25章:西班牙市場

第26章 東歐市場

第27章:俄羅斯市場

第28章 北美市場

第29章:美國市場

第30章:加拿大市場

第31章 南美洲市場

第32章:巴西市場

第33章 中東市場

第34章:非洲市場

第35章 市場監理與投資環境

第36章:競爭格局與公司概況

  • 即時偵測HbA1c市場:競爭格局及市場佔有率,2024年
  • POC HbA1c 檢測市場:公司評估矩陣
  • 即時檢測糖化血紅素市場:公司概況
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Bio-Rad Laboratories Inc
    • Menarini Group
    • Danaher Corporation

第37章:其他領先和創新企業

  • Tosoh Bioscience Inc, ARKRAY Inc, i-SENS, Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech, Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia

第38章:全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章:高潛力市場國家、細分市場與策略

  • 2030年即時檢測HbA1c市場:提供新機會的國家
  • 2030年即時檢測HbA1c市場:新興細分市場機會
  • 2030年即時檢測HbA1c市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MPHTB01_G26Q1

POC HbA1C testing devices are designed for diagnosing average levels of glucose in patients' blood and managing both type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs when either an inadequate amount of insulin is produced by the pancreas or when the body cannot use the insulin it produces effectively. POC HbA1C testing assesses the average level of blood sugar over 2 to 3 months in an individual.

The main products of POC HbA1C testing include instruments and consumables. Instruments refer to measuring devices for determining the present value of a quantity under observation. The technologies involved in POC HbA1C testing include ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and others. Various end-users utilize these testing devices, including hospitals, physician offices or outpatient centers, home care providers, and other end-users.

Tariffs are impacting the poc hba1c testing market by increasing costs of imported reagents, biosensors, electronic components, and diagnostic consumables used in instruments and test kits. Hospitals and outpatient care providers in North America and Europe are most affected due to reliance on imported diagnostic devices, while Asia-Pacific faces pricing pressure on device manufacturing. These tariffs are raising device procurement costs and slowing replacement cycles. However, they are also encouraging localized manufacturing, regional reagent production, and innovation in cost-efficient point-of-care testing solutions.

The poc hba1c testing market research report is one of a series of new reports from The Business Research Company that provides poc hba1c testing market statistics, including poc hba1c testing industry global market size, regional shares, competitors with a poc hba1c testing market share, detailed poc hba1c testing market segments, market trends and opportunities, and any further data you may need to thrive in the poc hba1c testing industry. This poc hba1c testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The poc hba1c testing market size has grown rapidly in recent years. It will grow from $1.02 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to rising prevalence of diabetes globally, increased clinical reliance on long-term glucose monitoring, expansion of outpatient diagnostic services, growing awareness of early diabetes diagnosis, availability of compact diagnostic instruments.

The poc hba1c testing market size is expected to see rapid growth in the next few years. It will grow to $1.76 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing adoption of decentralized diagnostics, rising demand for home care testing solutions, expansion of digital diabetes management programs, growing focus on preventive healthcare, increasing investments in rapid diagnostic technologies. Major trends in the forecast period include increasing adoption of rapid point-of-care hba1c devices, growing use of portable and handheld testing systems, rising demand for home-based diabetes monitoring, expansion of integrated poc diagnostic platforms, enhanced focus on test accuracy and standardization.

The rising global burden of diabetes is fueling growth in point-of-care (POC) HbA1c testing. Diabetes is a chronic metabolic condition marked by persistently high blood glucose levels, requiring regular monitoring to reduce the risk of complications such as neuropathy, cardiovascular disorders, and kidney damage. The growing incidence of diabetes is largely attributed to sedentary lifestyles, poor dietary habits, increasing obesity rates, and aging populations worldwide. As a result, demand is increasing for rapid, convenient, and reliable glycemic assessment across clinics, pharmacies, and home-care environments, where POC HbA1c testing enables timely clinical decisions. For example, in 2025, according to the International Diabetes Federation, approximately 589 million adults aged 20-79 were living with diabetes in 2024, with projections indicating this figure could rise to 853 million by 2050, and more than four out of five affected adults residing in low- and middle-income countries. This expanding patient base is therefore supporting continued growth in POC HbA1c testing.

Companies operating in the point-of-care HbA1c testing space are increasingly incorporating embedded internal verification systems to improve accuracy, minimize errors, and strengthen confidence in near-patient diagnostics. These automated self-check features continuously assess environmental conditions, sample quality, and assay performance during each test, helping to prevent inaccurate results. For instance, in July 2024, Siemens Healthineers launched its next-generation Atellica DCA Analyzer for point-of-care use. The system integrates proprietary Auto-Checks Technology that performs continuous internal calibrations throughout the testing process, including checks for environmental stability, airflow and temperature control, sample volume and integrity, optical clarity, and analytical precision. This automated monitoring enables delivery of lab-comparable HbA1c results within 4-5 minutes while reducing dependence on operator oversight. Such capabilities help lower pre-analytical error rates, enhance result reliability, and facilitate wider adoption of point-of-care testing in resource-limited settings.

In February 2024, HemoCue AB, a Sweden-based provider of POC HbA1c testing solutions including the HemoCue HbA1c 501 System, entered into a strategic partnership with Novo Nordisk to expand diabetes diagnosis and monitoring for children in low- and middle-income countries. Under this collaboration, HemoCue supports Novo Nordisk's Changing Diabetes in Children programme, which delivered free, life-saving diabetes treatment to more than 52,000 children in the previous year and has set a target of reaching 100,000 children by 2030. The partnership underscores a shared commitment to improving access to early diagnosis and ongoing glycemic monitoring for pediatric patients with type 1 diabetes in underserved regions.

Major companies operating in the poc hba1c testing market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, Bionime Corporation

North America was the largest region in the POC HbA1C testing market in 2025. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in the poc hba1c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the poc hba1c testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The POC HbA1C testing market consists of sales of small instruments, portable instruments, and HbA1C testing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Poc Hba1C Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses poc hba1c testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for poc hba1c testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The poc hba1c testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type of Product: Instruments; Consumables
  • 2) By Technology: Ion-Exchange HPLC; Enzymatic Assay; Affinity Binding Chromatography; Immunoassay; Other Technologies
  • 3) By End User: Hospitals; Physician Office Or Outpatient Center; Home Care; Other End Users
  • Subsegments:
  • 1) By Instruments: Handheld HbA1c Testing Devices; Portable HbA1c Analyzers; Desktop HbA1c Testing Systems; Integrated Point Of Care Testing Systems
  • 2) By Consumables: Test Strips; Control Solutions; Reagents; Calibration Solutions; Sample Collection Devices
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Siemens Healthineers AG; Bio-Rad Laboratories Inc; Menarini Group; Danaher Corporation; Tosoh Bioscience Inc; ARKRAY Inc; i-SENS Inc; Abbott Laboratories; Trinity Biotech plc; Aina Blood Monitoring System; Getein Biotech Inc; Sugentech Inc; Alere Inc; EKF Diagnostics; HemoCue; PTS Diagnostics; Osang Healthcare; Ortho Clinical Diagnostics; Ascensia; Platinum Equity (LifeScan); Becton Dickinson and Company; Kainico Ltd; Evia Medical Technologies; Agamatrix Inc; Bionime Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Poc Hba1C Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Poc Hba1C Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Poc Hba1C Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Poc Hba1C Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Rapid Point-Of-Care Hba1C Devices
    • 4.2.2 Growing Use Of Portable And Handheld Testing Systems
    • 4.2.3 Rising Demand For Home-Based Diabetes Monitoring
    • 4.2.4 Expansion Of Integrated Poc Diagnostic Platforms
    • 4.2.5 Enhanced Focus On Test Accuracy And Standardization

5. Poc Hba1C Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Physician Offices And Outpatient Centers
  • 5.3 Diagnostic Laboratories
  • 5.4 Home Care Providers
  • 5.5 Diabetes Care Clinics

6. Poc Hba1C Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Poc Hba1C Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Poc Hba1C Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Poc Hba1C Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Poc Hba1C Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Poc Hba1C Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Poc Hba1C Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Poc Hba1C Testing Market Segmentation

  • 9.1. Global Poc Hba1C Testing Market, Segmentation By Type of Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Consumables
  • 9.2. Global Poc Hba1C Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies
  • 9.3. Global Poc Hba1C Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users
  • 9.4. Global Poc Hba1C Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems
  • 9.5. Global Poc Hba1C Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices

10. Poc Hba1C Testing Market Regional And Country Analysis

  • 10.1. Global Poc Hba1C Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Poc Hba1C Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Poc Hba1C Testing Market

  • 11.1. Asia-Pacific Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Poc Hba1C Testing Market

  • 12.1. China Poc Hba1C Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Poc Hba1C Testing Market

  • 13.1. India Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Poc Hba1C Testing Market

  • 14.1. Japan Poc Hba1C Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Poc Hba1C Testing Market

  • 15.1. Australia Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Poc Hba1C Testing Market

  • 16.1. Indonesia Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Poc Hba1C Testing Market

  • 17.1. South Korea Poc Hba1C Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Poc Hba1C Testing Market

  • 18.1. Taiwan Poc Hba1C Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Poc Hba1C Testing Market

  • 19.1. South East Asia Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Poc Hba1C Testing Market

  • 20.1. Western Europe Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Poc Hba1C Testing Market

  • 21.1. UK Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Poc Hba1C Testing Market

  • 22.1. Germany Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Poc Hba1C Testing Market

  • 23.1. France Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Poc Hba1C Testing Market

  • 24.1. Italy Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Poc Hba1C Testing Market

  • 25.1. Spain Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Poc Hba1C Testing Market

  • 26.1. Eastern Europe Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Poc Hba1C Testing Market

  • 27.1. Russia Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Poc Hba1C Testing Market

  • 28.1. North America Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Poc Hba1C Testing Market

  • 29.1. USA Poc Hba1C Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Poc Hba1C Testing Market

  • 30.1. Canada Poc Hba1C Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Poc Hba1C Testing Market

  • 31.1. South America Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Poc Hba1C Testing Market

  • 32.1. Brazil Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Poc Hba1C Testing Market

  • 33.1. Middle East Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Poc Hba1C Testing Market

  • 34.1. Africa Poc Hba1C Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Poc Hba1C Testing Market, Segmentation By Type of Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Poc Hba1C Testing Market Regulatory and Investment Landscape

36. Poc Hba1C Testing Market Competitive Landscape And Company Profiles

  • 36.1. Poc Hba1C Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Poc Hba1C Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Poc Hba1C Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Menarini Group Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Poc Hba1C Testing Market Other Major And Innovative Companies

  • Tosoh Bioscience Inc, ARKRAY Inc, i-SENS, Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech, Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia

38. Global Poc Hba1C Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Poc Hba1C Testing Market

40. Poc Hba1C Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Poc Hba1C Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Poc Hba1C Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Poc Hba1C Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer